Normal view MARC view ISBD view

Annual report 2005 : selected issues / European Monitoring Centre for Drugs and Drug Addiction, EMCDDA

Autor institucional: EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTIONIdioma: Inglês.Publicação: Luxembourg : Office for Official Publications of the European Communities, 2005 Descrição física: 45 p.; 30 cmISBN: 9291682462Assunto: 299235 | 320197 | 225048 | 410441 | 343339 | 224774Resumo: Introductory note. Selected issue 1: Drug-related public nuisance - trends in policy and preventive measures: Definition, genesis and extent of the phenomenon; Policy and measures; Conclusions; References. Selected issue 2: Alternatives to imprisonment - targeting offending problem drug users in the EU: Introduction; Policy and legal development; Organisation and administration; Implementation; Evaluation and research; Conclusions; References. Selected issue 3: Buprenorphine - treatment, misuse and prescription practices: Overview; Introduction: legislation and pharmacological action; Treatment provision of buprenorphine; Misuse of buprenorphine; Conclusions; References.
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Copy number Status Date due Barcode
Monografias Biblioteca da Polícia Judiciária
PJ18.E.73 (Browse shelf) PJ26745 Available PJ126745

Disponível em: https://issues05.emcdda.eu.int/en/home-en.html.

Introductory note. Selected issue 1: Drug-related public nuisance - trends in policy and preventive measures: Definition, genesis and extent of the phenomenon; Policy and measures; Conclusions; References. Selected issue 2: Alternatives to imprisonment - targeting offending problem drug users in the EU: Introduction; Policy and legal development; Organisation and administration; Implementation; Evaluation and research; Conclusions; References. Selected issue 3: Buprenorphine - treatment, misuse and prescription practices: Overview; Introduction: legislation and pharmacological action; Treatment provision of buprenorphine; Misuse of buprenorphine; Conclusions; References.

There are no comments for this item.

Log in to your account to post a comment.